BRCA1 and BRCA2 are genes that produce proteins responsible for repairing damaged DNA, and mutations in these genes significantly increase the risk of breast and ovarian cancers. Genetic testing for these mutations can guide preventive measures and treatment strategies, making them critical in personalized medicine for cancer prevention and management.